Granite Shares Advisors LLC Eli Lilly & CO Transaction History

Granite Shares Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$350.74 - $468.98 $99,610 - $133,190	-284 Reduced 9.62%	2,667 $1.25 Million
Q1 2023 Apr 24, 2023	BUY	$310.63 - $364.82 $23,607 - $27,726	76 Added 2.64%	2,951 $1.01 Million
Q4 2022 Jan 26, 2023	SELL	$321.55 - $374.67 $150,485 - $175,345	-468 Reduced 14.0%	2,875 $0
Q3 2022 Oct 14, 2022	SELL	$296.48 - $337.87 $180,556 - $205,762	-609 Reduced 15.41%	3,343 $1.08 Million
Q2 2022 Jul 22, 2022	SELL	$278.73 - $327.27 $67,731 - $79,526	-243 Reduced 5.79%	3,952 $1.28 Million
Q1 2022 May 06, 2022	SELL	$234.69 - $291.66 $95,049 - $118,122	-405 Reduced 8.8%	4,195 $1.2 Million
Q4 2021 Feb 08, 2022	BUY	$224.85 - $279.04 $1.03 Million - $1.28 Million	4,600 New	4,600 $1.27 Million

3,887

763M

6.34M

7.97M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Granite Shares Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Granite Shares Advisors LLC with notifications on news.